Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow, India.
Eur J Med Chem. 2012 Sep;55:195-204. doi: 10.1016/j.ejmech.2012.07.018. Epub 2012 Jul 23.
An efficient one pot synthesis of a series of pluripotent (E)-1-(3-methyl-5-aryl-7-styryl-5H-thiazolo[3,2-a]pyrimidin-6-yl)-3-arylprop-2-en-1-ones is reported. It involves reaction of 5-acetyl-6-methyl-4-aryl-dihydropyrimidine-2-thiones, propargyl bromide and aromatic aldehydes in presence of ethanolic KOH. The newly synthesized compounds were evaluated for antimalarial activity against Plasmodium falciparum and as HIV-RT inhibitors. Most of the compound displayed potent antimalarial activity with IC(50)<2 μg/mL. Compounds 6, 11 and 20 showed better activity against P. falciparum K1 strains in comparison to standard drug chloroquine. Compounds 6, 11, and 16 exhibited 73.44, 66.92, and 70.81% HIV-RT inhibition at 100 μg/mL.
报道了一种高效一锅法合成一系列多能的(E)-1-(3-甲基-5-芳基-7-苯乙炔基-5H-噻唑并[3,2-a]嘧啶-6-基)-3-芳基-2-丙烯-1-酮。它涉及在乙醇氢氧化钾存在下,5-乙酰基-6-甲基-4-芳基-二氢嘧啶-2-硫酮、丙炔溴和芳醛之间的反应。新合成的化合物被评估了对恶性疟原虫的抗疟活性和作为 HIV-RT 抑制剂的活性。大多数化合物表现出很强的抗疟活性,IC50<2μg/mL。与标准药物氯喹相比,化合物 6、11 和 20 对 P. falciparum K1 株表现出更好的活性。化合物 6、11 和 16 在 100μg/mL 时对 HIV-RT 的抑制率分别为 73.44%、66.92%和 70.81%。